1. Home
  2. MRUS vs IFS Comparison

MRUS vs IFS Comparison

Compare MRUS & IFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • IFS
  • Stock Information
  • Founded
  • MRUS 2003
  • IFS 1897
  • Country
  • MRUS Netherlands
  • IFS Peru
  • Employees
  • MRUS N/A
  • IFS N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • IFS Commercial Banks
  • Sector
  • MRUS Health Care
  • IFS Finance
  • Exchange
  • MRUS Nasdaq
  • IFS Nasdaq
  • Market Cap
  • MRUS 5.1B
  • IFS 4.2B
  • IPO Year
  • MRUS 2016
  • IFS 2019
  • Fundamental
  • Price
  • MRUS $68.95
  • IFS $39.42
  • Analyst Decision
  • MRUS Strong Buy
  • IFS Buy
  • Analyst Count
  • MRUS 13
  • IFS 1
  • Target Price
  • MRUS $92.15
  • IFS $30.00
  • AVG Volume (30 Days)
  • MRUS 629.8K
  • IFS 163.4K
  • Earning Date
  • MRUS 10-30-2025
  • IFS 11-11-2025
  • Dividend Yield
  • MRUS N/A
  • IFS 2.38%
  • EPS Growth
  • MRUS N/A
  • IFS 112.04
  • EPS
  • MRUS N/A
  • IFS 4.72
  • Revenue
  • MRUS $56,228,000.00
  • IFS $1,506,553,476.00
  • Revenue This Year
  • MRUS $48.69
  • IFS N/A
  • Revenue Next Year
  • MRUS $3.15
  • IFS $3.48
  • P/E Ratio
  • MRUS N/A
  • IFS $8.44
  • Revenue Growth
  • MRUS 59.77
  • IFS 39.88
  • 52 Week Low
  • MRUS $33.19
  • IFS $24.26
  • 52 Week High
  • MRUS $70.65
  • IFS $42.21
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 57.97
  • IFS 45.08
  • Support Level
  • MRUS $66.49
  • IFS $41.08
  • Resistance Level
  • MRUS $69.63
  • IFS $42.21
  • Average True Range (ATR)
  • MRUS 2.46
  • IFS 0.93
  • MACD
  • MRUS -0.07
  • IFS -0.16
  • Stochastic Oscillator
  • MRUS 78.37
  • IFS 12.75

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About IFS Intercorp Financial Services Inc.

Intercorp Financial Services Inc is a provider of banking, insurance, wealth management services and payments for retail customers and commercial clients in Peru. The company has four operating segments; the Banking segment includes Mainly loans, credit facilities, deposits, and current accounts, the Insurance segment provides life annuity products with single-premium payment and conventional life insurance products and other retail insurance products, the Wealth Management segment provides brokerage and investment management services. Its geographical segments include Peru and Panama.

Share on Social Networks: